3-D Matrix, Ltd. (TYO:7777)

Market Cap	21.73B
Revenue (ttm)	6.93B
Net Income (ttm)	-2.50B
Shares Out	110.29M
EPS (ttm)	-25.20
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	5,572,800
Average Volume	6,649,390
Open	198.00
Previous Close	193.00
Day's Range	195.00 - 209.00
52-Week Range	97.00 - 283.00
Beta	0.07
RSI	50.57
Earnings Date	Sep 11, 2025

About 3-D Matrix

3-D Matrix, Ltd. develops self-assembling peptide technology in Japan and internationally. It offers PuraMatrix, a self-assembling peptide hydrogel for use in the regenerative medicine, cell therapy, drug delivery systems, and other uses in various fields. The company was incorporated in 2004 and is based in Tokyo, Japan.

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2004
• Employees: 106
• Stock Exchange: Tokyo Stock Exchange
• Ticker Symbol: 7777

Financial Performance

In 2025, 3-D Matrix's revenue was 6.93 billion, an increase of 51.13% compared to the previous year's 4.59 billion. Losses were -2.50 billion, 880.8% more than in 2024.